7/5/18
MPPG announced today an agreement with Dynavax to provide Heplisav-B, their new adult Hepatitis Vaccine, to members at a 12% discount off of the catalog price.
This HepB-CpG vaccine was approved by the FDA in October 2017 and given a recommendation by the ACIP this past February and then detailed in the April 20th 2018 MMWR. HEPLISAV–B, indicated for those 18 years of age an older, has an impressive immunogenicity profile and is only 2 doses.
Dr. Paul Offit shares a quick video review of this novel hepatitis B vaccine at https://tinyurl.com/y8sedr6j
HEPLISAV-B is available through www.vaccineshoppe.com and www.vaxserve.com.